why hasn't anyone hired a lawyer to go after this swindler Tigue and the rest of these clowns? why haven't their land holdings not been liquadated and the proceeds handed over to the former shareholders/? didn't they have holdings in northern BC/Alberta and New Mexico??
The only good news would be the ouster of Gerald and his replacement with a new CEO who at least has an idea of what he's doing
In a report issued on Tuesday, researchers from Alzheimer’s Disease International say about 58 percent of all people with dementia live in developing countries and that by 2050, nearly half of all those with the disease
will live in Asia. Numbers are expected to rise with aging populations and as more cases are identified. If 27-3 even helps a small portion of this population it will be a blockbuster
Don't worry Adam Feurerstein will soon be coming out with a "hit" piece to try and say this trial "halt" was due to side effects etc and that Linda and NWBO are hiding the facts from the investors---hope he does and the price falls some more--will load up on any more dips
that has to be AMBS---I sold that underperformer and used the funds to buy AVXL--the CEO of AMBS is simply too inexperienced and isn't meeting any of the timelines he's set out (why isn't Lymphopro not marketed yet?)---if they get a new CEO may invest in AMBS again but not now
why panic?? there's no bad news doing this--everything is on schedule--many catalysts to follow (updates on the first 3 patients/enrollment of patient #4/#5/details on the design of the pivotal study and the likelihood of a stem cell partner and NSS + scaffold trial---this dip in the pps gives me the chance to buy more shares
words can't express how sorry I am for what you are going through--to have a loved one go through this is something no one should have to experience--I hope 2-73 fulfills all the promise it has so far shown in the early trials
completely agree--the entire biotech sector is in the "dumps"--now is the time to take advantage of the low prices while they last--once patient #4/#5 are enrolled and ultimately also demonstrate neurologic improvement $20 pps will also be a thing of the past
Is management supposed to go out and injure potential patients so they can qualify for the study? the results will speak for themselves-we don't need a "snake oil salesman" going forth cheerleading this company to drive the pps up to appease impatient investors like you--there is NO bad news, everything is on schedule--so what's the problem here? if you want to make a quick buck go to the casino or buy a lottery ticket
You tell me your agenda FIRST PAL! I have a PhD in neuroscience-I want to see this scaffold improve the lives of many patients who have been confined to a wheelchair--I don't know what your "angle" is--I hope you aren't a confidant of "immansidope"--if so I suggest you invest in AVXL-they're doing ground breaking work on dementia
Perrin did layoff many employees when he streamlined the company to focus on the scaffold (put the hydrogel on hold etc)---wouldn't be surprised if Immansidope was part of the group let go--his tirades are the only way he can deal with his anger---Very Sad
"Medical Tourists" including spinal cord injured patients have spent small fortunes going to China for these treatments-stem cells etc---the results have been mediocre to terrible---this will be absolutely no different--don't feed "trolls" like immansidope-he feeds on creating a reaction
"fairly valued at $26 per share"
I think this is a "low ball" estimate--when patient #4/#5 further confirm that neurologic benefit occurs when using the scaffold (which they will) there will be "big time" media coverage of this company and what they're doing--don't under estimate the public interest in driving the pps higher--the reality is In Vivo is "under the radar" for most of the public and investors in general
don't believe the timelines set out in this article---suggesting won't get scaffold to market until later 2017-early 2018 if then----if patient #4/#5 show exempliary results (which they will)-you can be sure the FDA and NVIV will sit down and design the pivotal study in such a way as to expediate this device to market ASAP-I'm sure future newly spinal cord injured patients and their families are going to be demanding access to this technology and I can't see how even on compassionate grounds they wouldn't be allowed to get it
thanks alot for the summary--essentially describes the DD I did when I first heard about AVXL-I'm very excited to see what happends when the dosage of 2-73 is ultimately optimized--?will the cognitive benefits be even greater? would like to know if patients with much further progressed dementia/AD could benefit also---there are also other neurologic degenerative brain diseases--Picks disease etc---would this drug have similar efficacy in these conditions?
My best to your mother
--I also have a relative in the early stages of dementia--tragic to watch and not be able to do anything about it (Aricept may delay the progression but ultimately it does progress)
---I think if the results continue to be outstanding there needs to be some way to accelerate the development of this drug (the government will be facing a huge epidemic of dementia as baby boomers age and the cost to society is going to be astronomical)
I'd rather see tax dollars spent on something like this than on all the other infinite ways money is wasted now